freedomdiagnosticstesting.com publishes a public verification portal. Any test attributed to this lab can be looked up and confirmed directly with the lab — so this result doesn't rest on our review alone.
This certificate carries no lookup code.
This is a purity and identity analysis. Sterility, endotoxins, and heavy metals were not screened — a high purity figure says nothing about those.
Label 10 mg · Lab measured 11.08 mg
111% of label, basis not stated — shown as printed. Reconstituted with 2 mL, a 50-unit draw holds 2.8 mg using the measured mass, against 2.5 mg on the label — 11% more.
One vial from this lot was weighed by the laboratory, not yours. This page reports what the certificate says; it does not recommend a dose.
Independent HPLC purity analysis of N-Acetyl Semax Amidate from ionpeptide.com, performed by freedomdiagnosticstesting.com on October 14, 2025. Reported purity: 99.32%. Net content: 11.08 mg against 10 mg labeled (111% of label). Tested content exceeds the labeled amount by 11%. Batch SX10-1025. Sample source: shop-provided. Certificate of analysis attached.
| Lot | Tested | Lab | Purity | vs label | Status |
|---|---|---|---|---|---|
| SSB20-03102026 | 16 Mar 2026 | Analytical Formulations Inc | 99.2% | 106% | Lab has no portal |
| SXSK10-011626 | 21 Jan 2026 | freedomdiagnosticstesting.com | 98.74% | 101% | Unverified |
| SX10-12125 | 8 Dec 2025 | freedomdiagnosticstesting.com | 99.445% | 129% | Unverified |
| SSK1-1125 | 23 Nov 2025 | freedomdiagnosticstesting.com | 98.96% | 98% | Unverified |
| SX10-1125 | 16 Nov 2025 | freedomdiagnosticstesting.com | 98.913% | 103% | Unverified |
| SSB-1129 | 9 Nov 2025 | freedomdiagnosticstesting.com | 99.43% | 165% | Unverified |
| SMX10-1025 | 29 Oct 2025 | freedomdiagnosticstesting.com | 99.718% | 95% | Unverified |
Batches this shop has published a certificate for, newest first. A lot whose printed value cannot identify a batch is not listed.
Submit your third-party lab test to help the community verify purity claims. Every report is reviewed before publication.
Community discussion